BDKRB2 antibody (N-Term)
Quick Overview for BDKRB2 antibody (N-Term) (ABIN630235)
Target
See all BDKRB2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Specificity
- Bradykinin Receptor B2 antibody was raised against the N terminal of BDKRB2
-
Purification
- Purified
-
Immunogen
- Bradykinin Receptor B2 antibody was raised using the N terminal of BDKRB2 corresponding to a region with amino acids MFSPWKISMFLSVREDSVPTTASFSADMLNVTLQGPTLNGTFAQSKCPQV
-
-
-
-
Application Notes
-
WB: 5 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
Bradykinin Receptor B2 Blocking Peptide, (ABIN5612357), is also available for use as a blocking control in assays to test for specificity of this Bradykinin Receptor B2 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of BDKRB2 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- BDKRB2 (Bradykinin Receptor B2 (BDKRB2))
-
Alternative Name
- Bradykinin Receptor B2
-
Background
- BDKRB2 is a receptor for bradykinin. The 9 aa bradykinin peptide elicits many responses including vasodilation, edema, smooth muscle spasm and pain fiber stimulation. This receptor associates with G proteins that stimulate a phosphatidylinositol-calcium second messenger system.
-
Molecular Weight
- 43 kDa (MW of target protein)
-
Pathways
- ACE Inhibitor Pathway, Negative Regulation of intrinsic apoptotic Signaling
Target
-